A. Melis et al., Insulin-like growth factor inhibits vascular contraction to 5-hydroxytryptamine: Involvement of tyrosine phosphatase, GEN PH-VASC, 34(2), 2000, pp. 137-145
This study tests the hypothesis that insulin-like growth factor 1 (IGF-1)-i
nduced vasodilation is due to the stimulation of tyrosine phosphatase. Rat
aortic segments (endothelium intact) were placed in muscle baths for force
measurement. Segments were contracted to serotonin [5-hydroxytyptamine (5-H
T), 10(-7)10(-5) M] before and after incubation with IGF-1 (10-100 nM; 90 m
in). IGF-1 caused a 20% inhibition of 5-HT-induced contractions. This inhib
ition was reversed by the tyrosine phosphatase inhibitors sodium orthovanad
ate and molybdate, Orthovanadate did not alter inhibitory properties of the
calcium channel antagonist verapamil, suggesting that the phosphatase inhi
bitors were relatively specific. IGF-1-induced inhibition was not altered b
y blockade of nitric oxide synthase. Western blot analysis confirmed that t
he 5-HT-induced stimulation of tyrosine phosphorylation of the 42-kDa extra
cellular signal-regulated mitogen-activated protein kinase protein was redu
ced by IGF-1 (52% inhibition), an inhibition that was attenuated by orthova
nadate. These data are consistent with the hypothesis that the vasodilator
activity of IGF-1 is mediated by the activation of a tyrosine phosphatase.
(C) 2000 Elsevier Science Inc. All rights reserved.